VanEck Biotech ETF (BBH) Holdings
BBH holdings summary
as of Oct 25, 2026- Holdings
- 25 positions listed
- Top 10 weight
- 72.4% of net assets
- Effective holdings
- 13 equal-weight equivalent
- Largest holding
- AMGN 15.55% Amgen Inc.
- Annual turnover
- 18.0% of the portfolio traded
All BBH holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | AMGN | Amgen Inc. | Healthcare | 15.55% | $78.1M | $233.82B | 26.9 |
| 2 | GILD | Gilead Sciences, Inc. | Healthcare | 13.66% | $68.6M | $193.67B | — |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 8.40% | $42.2M | $126.66B | 28.9 |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 7.02% | $35.2M | $81.41B | 19.6 |
| 5 | MRNA | Moderna, Inc. | Healthcare | 6.49% | $32.6M | $87.04B | — |
| 6 | NTRA | Natera, Inc. | Healthcare | 4.70% | $23.6M | $56.71B | — |
| 7 | IQV | IQVIA Holdings Inc. | Healthcare | 4.54% | $22.8M | $43.93B | 33.2 |
| 8 | ARGX | argenx SE | Healthcare | 4.22% | $21.2M | $51.51B | 31.2 |
| 9 | ILMN | Illumina, Inc. | Healthcare | 4.08% | $20.5M | $39.64B | 49.0 |
| 10 | RVMD | Revolution Medicines, Inc. | Healthcare | 3.75% | $18.8M | $38.14B | — |
| 11 | BIIB | Biogen Inc. | Healthcare | 3.08% | $15.5M | $34.37B | 41.3 |
| 12 | ONC | BeiGene, Ltd. | Healthcare | 2.82% | $14.2M | $41.99B | 66.0 |
| 13 | GH | Guardant Health, Inc. | Healthcare | 2.74% | $13.8M | $21.28B | — |
| 14 | UTHR | United Therapeutics Corporation | Healthcare | 2.36% | $11.8M | $22.87B | 19.1 |
| 15 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 2.33% | $11.7M | $31.02B | 39.1 |
| 16 | INCY | Incyte Corporation | Healthcare | 2.16% | $10.9M | $22.92B | 14.4 |
| 17 | INSM | Insmed Incorporated | Healthcare | 1.67% | $8.4M | $21.02B | — |
| 18 | CRL | Charles River Laboratories International, Inc. | Healthcare | 1.66% | $8.4M | $14.46B | — |
| 19 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 1.44% | $7.2M | $13.79B | 19.9 |
| 20 | BNTX | BioNTech SE | Healthcare | 1.35% | $6.8M | $22.03B | — |
| 21 | ICLR | ICON Public Limited Company | Healthcare | 1.34% | $6.7M | $13.13B | 179.1 |
| 22 | TECH | Bio-Techne Corporation | Healthcare | 1.15% | $5.8M | $11.38B | 62.6 |
| 23 | QGEN | Qiagen N.V. | Healthcare | 1.04% | $5.2M | $9.53B | 23.4 |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 0.99% | $5.0M | $10.58B | 147.8 |
| 25 | TEM | Tempus AI, Inc. | Healthcare | 0.93% | $4.7M | $11.68B | — |
Weights as a percentage of net assets. Value held = weight × net assets ($502.0M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
BBH sector breakdown
Sum of the weights of the holdings in each sector.
BBH top industries
BBH overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| IBB | iShares Biotechnology ETF | 65.1% | 21 of 234 | 0.46% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 57.1% | 19 of 245 | 0.18% |
| DIA | SPDR Dow Jones Industrial Average ETF | 5.1% | 1 of 30 | 0.16% |
| QQQ | Invesco QQQ ETF | 3.3% | 6 of 101 | 0.17% |
| VTI | Vanguard Total Stock Market ETF | 1.5% | 20 of 2,941 | 0.03% |
| SPY | SPDR S&P 500 ETF | 1.3% | 11 of 502 | 0.09% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the BBH portfolio
VanEck Biotech ETF holds 25 positions. The ten largest make up 72.4% of the fund, so it behaves like a portfolio of about 13 equally weighted stocks. The biggest positions are Amgen Inc. (15.55%), Gilead Sciences, Inc. (13.66%), Vertex Pharmaceuticals Incorporated (8.40%), Regeneron Pharmaceuticals, Inc. (7.02%), Moderna, Inc. (6.49%).
By sector, Healthcare is 99.5%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: BBH chart, BBH performance, BBH dividends, BBH valuation, BBH overview.
BBH holdings FAQ
How many holdings does BBH have?
BBH holds 25 positions as of October 25, 2026.
What are the top 10 holdings of BBH?
The ten largest holdings are Amgen Inc. (15.55%), Gilead Sciences, Inc. (13.66%), Vertex Pharmaceuticals Incorporated (8.40%), Regeneron Pharmaceuticals, Inc. (7.02%), Moderna, Inc. (6.49%), Natera, Inc. (4.70%), IQVIA Holdings Inc. (4.54%), argenx SE (4.22%), Illumina, Inc. (4.08%), Revolution Medicines, Inc. (3.75%). Together they are 72.4% of the fund.
What percentage of BBH is Amgen Inc.?
Amgen Inc. is the largest holding at 15.55% of net assets, about $78.1M of the fund's $502.0M.
How concentrated is BBH?
The top 10 holdings are 72.4% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) BBH behaves like a portfolio of about 13 equally weighted stocks.